# Oxford Medical Simulation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oxford-medical-simulation

- Industry: Software
- Headquarters: Somerville, US
- Website: www.oxfordmedicalsimulation.com/
- Total disclosed funding: $13M
- Latest round: Series A (Jan 12, 2024)
- Investors on record: 4

## About

Founded in 2017 and based in Massachusetts, US, Oxford Medical Simulation Inc., aka OMS, operates as a software platform that provides virtual reality (VR) medical simulation training for healthcare industries. Michael Wallace (CEO) and Jack Pottle (CMO) are the co-founders of the company. In March 2026, Oxford Medical Simulation Inc. raised GBP 5 million in growth capital funding from new investor Salica Investments. The company also has an office in the US.

The company offers a virtual reality (VR) and on-screen platform designed to enhance clinical training and education. The firm’s platform supports both self-directed and facilitated learning, delivering adaptive and standardized simulations that measure competency and improve clinical performance. OMS facilitates clinical placements, competency mapping, and performance-based feedback, thereby enhancing learning outcomes and operational efficiency in healthcare and academic settings.

The company plans to utilize the March 2026 funding to expand into U.S. health systems and academic institutions and invest in AI-driven simulation, analytics, and workflow tools.

## Funding rounds

- Series A, Jan 12, 2024, $13M — Frog Capital, ACF Investors
- Seed, May 1, 2019 — QVentures
- Seed, Jan 1, 2018 — Force Over Mass Capital

## Investors

- Force Over Mass Capital (https://capitalatlas.ai/funds/force-over-mass-capital) — Seed
- QVentures (https://capitalatlas.ai/funds/qventures) — Seed
- Frog Capital (https://capitalatlas.ai/funds/frog-capital) — Series A
- ACF Investors (https://capitalatlas.ai/funds/acf-investors) — Series A